Ornob Roy, MD
Urology · Charlotte, NCNPI 1891908430
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $11,217 of the $16,946 with a category attached, or 66.2%. Travere Therapeutics, Inc. accounts for 79.8% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $8,712 and has fallen 95.8% since, to $369 in 2025. Among urology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 81 payments — averaging $209.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Travere Therapeutics, Inc.$14K
- Boston Scientific$1K
- Urogen Pharma, Inc.$1K
- Johnson & Johnson$245
- Biom'up France SAS$209
- Olympus America Inc.$195
- plus $268 from 4 others
What the payments were for
- Consulting fees$1,5009%
- Speaking & faculty fees$11,21766%
- Travel & lodging$3032%
- Food & beverage$3,90823%
- Education$180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Travere Therapeutics, Inc. | 23 | $13,525 |
| Boston Scientific | 23 | $1,452 |
| Urogen Pharma, Inc. | 20 | $1,052 |
| Johnson & Johnson | 6 | $245 |
| Biom'up France SAS | 2 | $209 |
| Olympus America Inc. | 2 | $195 |
| Neotract Inc. | 1 | $132 |
| Intuitive Surgical | 2 | $97 |
| Covidien LP | 1 | $31 |
| Histosonics, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (815) Thiola$12,568
- JELMYTO$496
- LithoVue$322
- HemoBlast Bellows$209
- GENERAL ERECTILE DYSFUNCTION$174
- GENERAL - THERAPIES$147
- UroLift$132
- Enseal X1$124
- Harmonic$124
- STRATAFIX$124
- ECHELON ENDOPATH$124
- VISTASEAL$124
- REZUM$120
- iTIND System$117
How this compares
$16,946 in reported general payments places this provider in the 90th percentile of 434 urology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Citrate ErPotassium Citrate | 11 | $1,365 |
| Tamsulosin Hcl | 91 | $797 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 30 | $363 |
| Oxybutynin Chloride | 44 | $269 |
| Cefadroxil | 36 | $118 |
| Finasteride | 12 | $75 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $55 |
| Ciprofloxacin Hcl | 11 | $31 |
Paid to pharmacies, not to this prescriber.
Other urology in Charlotte
- Michael KennellyCharlotte$1.3M
- Manish PatelCharlotte$84K
- Kris GastonCharlotte$32K
- Todd CohenCharlotte$18K
- Maxim McKibbenCharlotte$15K
- Robert LippittSmithfield$11.4M
- John KasparRaleigh$1.1M
- Judd MoulDurham$1M
- Daniel GeorgeDurham$1M
- Scott MacdiarmidGreensboro$774K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.